Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 255

    1.

    Diabetes: Diabetes therapy and cancer risk.

    Vigneri R.

    Nat Rev Endocrinol. 2009 Dec;5(12):651-652. No abstract available. PMID: 19924151 [PubMed - as supplied by publisher]Related articles

    2.

    Papillary Thyroid Cancer Incidence in the Volcanic Area of Sicily.

    Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Frasca F, Malandrino P, Vermiglio F, Previtera DM, D'Azzò G, Trimarchi F, Vigneri R.

    J Natl Cancer Inst. 2009 Nov 18;101(22):1575-1583. Epub 2009 Nov 5.PMID: 19893009 [PubMed - as supplied by publisher]Related articles

    3.

    Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.

    Cefalù AB, Noto D, Arpi ML, Yin F, Spina R, Hilden H, Barbagallo CM, Carroccio A, Tarugi P, Squatrito S, Vigneri R, Taskinen MR, Péterfy M, Averna MR.

    J Clin Endocrinol Metab. 2009 Nov;94(11):4584-90. Epub 2009 Oct 9.PMID: 19820022 [PubMed - in process]Related articles

    4.

    Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

    Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R.

    Endocr Rev. 2009 Oct;30(6):586-623. Epub 2009 Sep 14.PMID: 19752219 [PubMed - in process]Related articles

    5.

    Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells.

    Genua M, Pandini G, Sisci D, Castoria G, Maggiolini M, Vigneri R, Belfiore A.

    Cancer Res. 2009 Sep 15;69(18):7270-7. Epub 2009 Sep 8.PMID: 19738069 [PubMed - indexed for MEDLINE]Related articles

    6.

    Managing impaired glucose metabolism in acromegalic subjects.

    Pezzino V, Sipione C, Tita P, Vigneri R.

    J Endocrinol Invest. 2009 Jul 21. [Epub ahead of print] No abstract available. PMID: 19625760 [PubMed - as supplied by publisher]Related articles

    7.

    Diabetes and cancer.

    Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R.

    Endocr Relat Cancer. 2009 Jul 20. [Epub ahead of print]PMID: 19620249 [PubMed - as supplied by publisher]Related articles

    8.

    Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

    Vigneri R, Frasca F, Sciacca L, Vigneri P, Frittitta L.

    J Natl Cancer Inst. 2009 Jul 15;101(14):1030-1; author reply 1031-2. Epub 2009 Jun 22. No abstract available. PMID: 19546433 [PubMed - indexed for MEDLINE]Related articles

    9.

    Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.

    Sacco A, Morcavallo A, Pandini G, Vigneri R, Belfiore A.

    Endocrinology. 2009 Aug;150(8):3594-602. Epub 2009 May 14.PMID: 19443570 [PubMed - indexed for MEDLINE]Related articles

    10.

    Continuing medical education and professional revalidation in Europe: five case examples.

    Maisonneuve H, Matillon Y, Negri A, Pallarés L, Vigneri R, Young HL.

    J Contin Educ Health Prof. 2009 Winter;29(1):58-62.PMID: 19288575 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

    Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Baldini N.

    Cancer Res. 2009 Mar 15;69(6):2443-52. Epub 2009 Mar 3.PMID: 19258511 [PubMed - indexed for MEDLINE]Related articles

    12.

    Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway.

    Pandini G, Genua M, Frasca F, Vigneri R, Belfiore A.

    Ann N Y Acad Sci. 2009 Feb;1155:263-7.PMID: 19250214 [PubMed - indexed for MEDLINE]Related articles

    13.

    DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.

    Vella V, Puppin C, Damante G, Vigneri R, Sanfilippo M, Vigneri P, Tell G, Frasca F.

    Int J Cancer. 2009 Jun 1;124(11):2539-48.PMID: 19173293 [PubMed - indexed for MEDLINE]Related articles

    14.

    Improving the diagnosis of central hypothyroidism.

    Pezzino V, Sipione C, Vigneri R.

    J Endocrinol Invest. 2008 Oct;31(10):939. No abstract available. PMID: 19092302 [PubMed - indexed for MEDLINE]Related articles

    15.

    Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization.

    Vettor R, Granzotto M, De Stefani D, Trevellin E, Rossato M, Farina MG, Milan G, Pilon C, Nigro A, Federspil G, Vigneri R, Vitiello L, Rizzuto R, Baratta R, Frittitta L.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3541-50. Epub 2008 Jun 26.PMID: 18583466 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The role of insulin receptors and IGF-I receptors in cancer and other diseases.

    Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R.

    Arch Physiol Biochem. 2008 Feb;114(1):23-37. Review.PMID: 18465356 [PubMed - indexed for MEDLINE]Related articles

    17.

    Longitudinal study of thyroid function in children with mild hyperthyrotropinemia at neonatal screening for congenital hypothyroidism.

    Leonardi D, Polizzotti N, Carta A, Gelsomino R, Sava L, Vigneri R, Calaciura F.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2679-85. Epub 2008 Apr 29.PMID: 18445672 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    BRAF(V600E) mutation and the biology of papillary thyroid cancer.

    Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R.

    Endocr Relat Cancer. 2008 Mar;15(1):191-205.PMID: 18310287 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.

    Malaguarnera R, Vella V, Pandini G, Sanfilippo M, Pezzino V, Vigneri R, Frasca F.

    Mol Cancer Res. 2008 Jan;6(1):64-77.PMID: 18234963 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

    Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L.

    Endocr Rev. 2008 Feb;29(1):62-75. Epub 2008 Jan 16. Review. Erratum in: Endocr Rev. 2009 Feb;30(1):117. PMID: 18199690 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.

    Pandini G, Genua M, Frasca F, Squatrito S, Vigneri R, Belfiore A.

    Cancer Res. 2007 Sep 15;67(18):8932-41. Erratum in: Cancer Res. 2007 Nov 1;67(21):10623. PMID: 17875736 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling.

    Frasca F, Pandini G, Malaguarnera R, Mandarino A, Messina RL, Sciacca L, Belfiore A, Vigneri R.

    J Biol Chem. 2007 Sep 7;282(36):26077-88. Epub 2007 Jul 9.PMID: 17620332 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Healing of chronic necrobiosis lipoidica lesions in a type 1 diabetic patient after pancreas-kidney transplantation: a case report.

    Gullo D, Latina A, Tomaselli L, Arpi ML, Squatrito S, Curatolo S, La Greca S, Vigneri R.

    J Endocrinol Invest. 2007 Mar;30(3):259-62.PMID: 17505163 [PubMed - indexed for MEDLINE]Related articles

    24.

    p53 family proteins in thyroid cancer.

    Malaguarnera R, Vella V, Vigneri R, Frasca F.

    Endocr Relat Cancer. 2007 Mar;14(1):43-60. Review.PMID: 17395974 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy.

    Restivo DA, Marchese-Ragona R, Lauria G, Squatrito S, Gullo D, Vigneri R.

    Diabetes Care. 2006 Dec;29(12):2650-3.PMID: 17130199 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.

    Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R, Belfiore A.

    Endocrinology. 2006 Sep;147(9):4463-75. Epub 2006 Jun 15.PMID: 16777971 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    High prevalence of overweight and obesity in 11-15-year-old children from Sicily.

    Baratta R, Degano C, Leonardi D, Vigneri R, Frittitta L.

    Nutr Metab Cardiovasc Dis. 2006 May;16(4):249-55. Epub 2006 Jan 18.PMID: 16679216 [PubMed - indexed for MEDLINE]Related articles

    28.

    Aggressive fibromatosis of the neck initiated after thyroidectomy.

    Arena S, Salamone S, Cianci R, Scollo C, Masucci R, Giannone G, Manusia M, Vigneri R, La Rosa GL.

    J Endocrinol Invest. 2006 Jan;29(1):78-81.PMID: 16553038 [PubMed - indexed for MEDLINE]Related articles

    29.

    Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer.

    Regalbuto C, Alagona C, Maiorana R, Di Paola R, Cianci M, Alagona G, Sapienza S, Vigneri R, Pezzino V.

    J Endocrinol Invest. 2006 Jan;29(1):32-40.PMID: 16553031 [PubMed - indexed for MEDLINE]Related articles

    30.

    HMGA1 inhibits the function of p53 family members in thyroid cancer cells.

    Frasca F, Rustighi A, Malaguarnera R, Altamura S, Vigneri P, Del Sal G, Giancotti V, Pezzino V, Vigneri R, Manfioletti G.

    Cancer Res. 2006 Mar 15;66(6):2980-9.PMID: 16540646 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Obesity and cancer.

    Vigneri P, Frasca F, Sciacca L, Frittitta L, Vigneri R.

    Nutr Metab Cardiovasc Dis. 2006 Jan;16(1):1-7. No abstract available. PMID: 16399485 [PubMed - indexed for MEDLINE]Related articles

    32.

    Risk factors for congenital hypothyroidism: results of a population case-control study (1997-2003).

    Medda E, Olivieri A, Stazi MA, Grandolfo ME, Fazzini C, Baserga M, Burroni M, Cacciari E, Calaciura F, Cassio A, Chiovato L, Costa P, Leonardi D, Martucci M, Moschini L, Pagliardini S, Parlato G, Pignero A, Pinchera A, Sala D, Sava L, Stoppioni V, Tancredi F, Valentini F, Vigneri R, Sorcini M.

    Eur J Endocrinol. 2005 Dec;153(6):765-73.PMID: 16322381 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    The p53-homologue p63 may promote thyroid cancer progression.

    Malaguarnera R, Mandarino A, Mazzon E, Vella V, Gangemi P, Vancheri C, Vigneri P, Aloisi A, Vigneri R, Frasca F.

    Endocr Relat Cancer. 2005 Dec;12(4):953-71.PMID: 16322335 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    High prevalence of differentiated thyroid carcinoma in acromegaly.

    Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, degli Uberti EC, Pezzino V.

    Clin Endocrinol (Oxf). 2005 Aug;63(2):161-7.PMID: 16060909 [PubMed - indexed for MEDLINE]Related articles

    35.

    Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

    Pandini G, Mineo R, Frasca F, Roberts CT Jr, Marcelli M, Vigneri R, Belfiore A.

    Cancer Res. 2005 Mar 1;65(5):1849-57.PMID: 15753383 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells.

    Frasca F, Pandini G, Vigneri R, Goldfine ID.

    Breast Dis. 2003;17:73-89.PMID: 15687679 [PubMed]Related articles

    37.

    Neural network analysis for evaluating cancer risk in thyroid nodules with an indeterminate diagnosis at aspiration cytology: identification of a low-risk subgroup.

    Ippolito AM, De Laurentiis M, La Rosa GL, Eleuteri A, Tagliaferri R, De Placido S, Vigneri R, Belfiore A.

    Thyroid. 2004 Dec;14(12):1065-71.PMID: 15650360 [PubMed - indexed for MEDLINE]Related articles

    38.

    IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding.

    Pandini G, Conte E, Medico E, Sciacca L, Vigneri R, Belfiore A.

    Ann N Y Acad Sci. 2004 Dec;1028:450-6.PMID: 15650270 [PubMed - indexed for MEDLINE]Related articles

    39.

    Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases.

    Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A.

    J Clin Endocrinol Metab. 2004 Aug;89(8):3713-20.PMID: 15292295 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.

    Mineo R, Costantino A, Frasca F, Sciacca L, Russo S, Vigneri R, Belfiore A.

    Endocrinology. 2004 Sep;145(9):4355-65. Epub 2004 Jun 10.PMID: 15192042 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease.

    Vella V, Mineo R, Frasca F, Mazzon E, Pandini G, Vigneri R, Belfiore A.

    J Clin Endocrinol Metab. 2004 Jun;89(6):2880-9.PMID: 15181072 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.

    Baratta R, Amato S, Degano C, Farina MG, Patanè G, Vigneri R, Frittitta L.

    J Clin Endocrinol Metab. 2004 Jun;89(6):2665-71.PMID: 15181039 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Diabetic mastopathy: a case report.

    Giunta A, Vigneri R, Manusia M, Squatrito S, Tomaselli L.

    J Endocrinol Invest. 2003 Jul;26(7):683-5.PMID: 14594123 [PubMed - indexed for MEDLINE]Related articles

    44.

    Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms.

    Baratta R, Di Paola R, Spampinato D, Fini G, Marucci A, Coco A, Vigneri R, Frittitta L, Trischitta V.

    J Mol Med. 2003 Nov;81(11):718-23. Epub 2003 Oct 22.PMID: 14574455 [PubMed - indexed for MEDLINE]Related articles

    45.

    p73 tumor-suppressor activity is impaired in human thyroid cancer.

    Frasca F, Vella V, Aloisi A, Mandarino A, Mazzon E, Vigneri R, Vigneri P.

    Cancer Res. 2003 Sep 15;63(18):5829-37.PMID: 14522906 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation.

    Spampinato D, Giaccari A, Trischitta V, Costanzo BV, Morviducci L, Buongiorno A, Di Mario U, Vigneri R, Frittitta L.

    Metabolism. 2003 Sep;52(9):1092-5.PMID: 14506612 [PubMed - indexed for MEDLINE]Related articles

    47.

    Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A.

    Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, Belfiore A.

    J Biol Chem. 2003 Oct 24;278(43):42178-89. Epub 2003 Jul 24.PMID: 12881524 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.

    Sciacca L, Prisco M, Wu A, Belfiore A, Vigneri R, Baserga R.

    Endocrinology. 2003 Jun;144(6):2650-8.PMID: 12746329 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Exclusion of c-Abl from the nucleus restrains the p73 tumor suppression function.

    Vella V, Zhu J, Frasca F, Li CY, Vigneri P, Vigneri R, Wang JY.

    J Biol Chem. 2003 Jul 4;278(27):25151-7. Epub 2003 Apr 25.PMID: 12716888 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.

    Pellegriti G, Scollo C, Regalbuto C, Attard M, Marozzi P, Vermiglio F, Violi MA, Cianci M, Vigneri R, Pezzino V, Squatrito S.

    Clin Endocrinol (Oxf). 2003 May;58(5):556-61.PMID: 12699436 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...